• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症患者外周血T淋巴细胞亚群及血清细胞因子的变化

Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis.

作者信息

Guo Rong-Hong, Cheng Hao, Zhang Xiao-Ying, Yu Zhen, Wang Guang-Hui, Hao Shu-Ya, Gao Xiao-Peng, Wen Hong-Yan

机构信息

Department of Rheumatology, Shanxi Medical University, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

出版信息

Front Pharmacol. 2022 Nov 3;13:986199. doi: 10.3389/fphar.2022.986199. eCollection 2022.

DOI:10.3389/fphar.2022.986199
PMID:36408259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9669295/
Abstract

T cells represent a predominant cell type in autoimmune disease. However, their exact roles are not fully clear in systemic sclerosis (SSc). This study aimed to mainly investigate the alteration in the absolute numbers of T-lymphocyte subsets and the serum levels of cytokines in SSc patients. A total of 76 patients with SSc and 76 age- and sex-matched healthy controls (HCs) were enrolled. The levels of circulating T cell subsets and serum cytokines were measured by flow cytometry. T cell subsets or serum cytokines correlations with disease activity and organ involvement were analyzed. The absolute numbers of Th2 and Treg cells in SSc patients were lower than those in HCs ( < 0.05), resulting in the ratios of Th1/Th2 [25.01 (12.24, 38.61) vs. 11.64 (6.38, 20.34)] and Th17/Treg [0.42 (0.17, 0.66) vs. 0.17 (0.13, 0.29)] were increased significantly ( < 0.001). The absolute numbers of total T, Th, and Treg cells were negatively correlated with CRP ( = -0.406, = 0.002; = -0.263, < 0.05; = -0.367 < 0.01). The serum levels of IL-2, SIL-2R, IL-6, IL-10, INF-γ, and TNF-α were significantly higher than those in HCs ( < 0.001). Increasing IL-2 in the wake of the augment of ESR ( = 0.671, = 0.004), so did IL-6 ( = 0.378, < 0.05). The ratio of Th17/Treg in SSc-ILD patients had lower levels than that in other patients [0.35 (0.14, 0.53) vs. 0.64 (0.26, 0.93) = 0.028]; Treg cells were lessened in patients with Raynaud's phenomenon relative to controls [3.00 (2.41, 4.28) vs. 3.55 (2.86, 4.53) < 0.05]. The levels of IL-2, IL-10 and INF-γ [3.32 (1.05,11.73) vs. 2.32 (0.44,6.45), = 0.045], [8.08 (3.63, 355,77) vs. 4.89 (0.78, 21.44), = 0.02], [6.31 (2.66, 44.03) vs. 4.03 (0.22, 16.96), = 0.009] were elevated in patients with arthralgia, while the level of Th17 was decreased [0.62 (0.20,2.16) vs. 1.26 (0.22,10.93), = 0.026]. ROC curve analysis yielded an optimal cut-off IL-2, IL-10, and INF-γ levels of 2.67, 5.93, and 5.32 pg/ml for the presence of arthralgia. We exhibited abnormalities in T subsets and the production of their cytokines in SSc, as compared with those in HCs. This may allow the pathogenesis of SSc and the development of novel therapeutic interventions aimed at targeting these cells and the cytokines they produce.

摘要

T细胞是自身免疫性疾病中的主要细胞类型。然而,它们在系统性硬化症(SSc)中的确切作用尚不完全清楚。本研究旨在主要调查SSc患者T淋巴细胞亚群的绝对数量变化以及细胞因子的血清水平。共纳入76例SSc患者和76例年龄及性别匹配的健康对照(HC)。通过流式细胞术检测循环T细胞亚群水平和血清细胞因子。分析了T细胞亚群或血清细胞因子与疾病活动度和器官受累情况的相关性。SSc患者中Th2和Treg细胞的绝对数量低于HC(<0.05),导致Th1/Th2比值[25.01(12.24,38.61)对11.64(6.38,20.34)]和Th17/Treg比值[0.42(0.17,0.66)对0.17(0.13,0.29)]显著升高(<0.001)。总T细胞、Th细胞和Treg细胞的绝对数量与CRP呈负相关(r = -0.406,P = 0.002;r = -0.263,P < 0.05;r = -0.367,P < 0.01)。SSc患者血清IL-2、SIL-2R、IL-6、IL-10、INF-γ和TNF-α水平显著高于HC(<0.001)。ESR升高后IL-2增加(r = 0.671,P = 0.004),IL-6也如此(r = 0.378,P < 0.05)。SSc-ILD患者的Th17/Treg比值低于其他患者[0.35(0.14,0.53)对0.64(0.26,0.93),P = 0.028];相对于对照组,雷诺现象患者的Treg细胞减少[3.00(2.41,4.28)对3.55(2.86,4.53),P < 0.05]。关节痛患者的IL-2、IL-10和INF-γ水平升高[3.32(1.05,11.73)对2.32(0.44,6.45),P = 0.045],[8.08(3.63,355.77)对4.89(0.78,21.44),P = 0.02],[6.31(2.66,44.03)对4.03(0.22,16.9,6),P = 0.009],而Th17水平降低[0.62(0.20,2.16)对1.26(0.22,10.93),P = 0.026]。ROC曲线分析得出关节痛存在时IL-2、IL-10和INF-γ的最佳截断水平分别为2.67、5.93和5.32 pg/ml。与HC相比,我们发现SSc患者的T亚群及其细胞因子产生存在异常。这可能有助于了解SSc的发病机制,并开发针对这些细胞及其产生的细胞因子的新型治疗干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d6/9669295/7fc0afd90997/fphar-13-986199-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d6/9669295/89aefb97997d/fphar-13-986199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d6/9669295/f78b80de74b5/fphar-13-986199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d6/9669295/b9485c59f703/fphar-13-986199-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d6/9669295/7fc0afd90997/fphar-13-986199-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d6/9669295/89aefb97997d/fphar-13-986199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d6/9669295/f78b80de74b5/fphar-13-986199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d6/9669295/b9485c59f703/fphar-13-986199-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d6/9669295/7fc0afd90997/fphar-13-986199-g004.jpg

相似文献

1
Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis.系统性硬化症患者外周血T淋巴细胞亚群及血清细胞因子的变化
Front Pharmacol. 2022 Nov 3;13:986199. doi: 10.3389/fphar.2022.986199. eCollection 2022.
2
Absolute decrease in regulatory T cells and low-dose interleukin-2 therapy: restoring and expanding regulatory T cells to treat systemic sclerosis: a 24-week study.调节性 T 细胞绝对减少和低剂量白细胞介素-2 治疗:恢复和扩增调节性 T 细胞治疗系统性硬化症:一项 24 周的研究。
Clin Exp Dermatol. 2022 Dec;47(12):2188-2195. doi: 10.1111/ced.15345. Epub 2022 Oct 2.
3
Elevated serum IL-2 and Th17/Treg imbalance are associated with gout.血清 IL-2 水平升高和 Th17/Treg 失衡与痛风有关。
Clin Exp Med. 2024 Jan 19;24(1):9. doi: 10.1007/s10238-023-01253-4.
4
Increased serum soluble interleukin-2 receptor levels in dermatomyositis are associated with Th17/Treg immune imbalance.皮肌炎患者血清可溶性白细胞介素-2 受体水平升高与 Th17/Treg 免疫失衡有关。
Clin Exp Med. 2023 Nov;23(7):3605-3617. doi: 10.1007/s10238-023-01155-5. Epub 2023 Aug 2.
5
Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.系统性硬化症患者中Th17细胞和CD4⁺CD25⁺调节性T细胞与临床参数的相关性
Chin Med J (Engl). 2014;127(20):3557-61.
6
Peripheral Th17/Treg imbalance in Chinese patients with untreated antisynthetase syndrome associated interstitial lung disease.中国未经治疗的抗合成酶综合征相关间质性肺病患者外周血 Th17/Treg 失衡。
Int Immunopharmacol. 2024 Sep 10;138:112403. doi: 10.1016/j.intimp.2024.112403. Epub 2024 Jun 26.
7
Decreased absolute number of peripheral regulatory T cells in patients with idiopathic retroperitoneal fibrosis.特发性腹膜后纤维化患者外周调节性 T 细胞绝对数减少。
Front Immunol. 2022 Nov 29;13:1012513. doi: 10.3389/fimmu.2022.1012513. eCollection 2022.
8
T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.系统性硬化症中T细胞和自然杀伤细胞的表型异常:一项队列研究及综合文献综述
Clin Rev Allergy Immunol. 2015 Dec;49(3):347-69. doi: 10.1007/s12016-015-8505-8.
9
Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients.系统性硬化症患者外周血中Treg/Th17细胞平衡及T淋巴细胞的植物血凝素激活
World J Exp Med. 2017 Aug 20;7(3):84-96. doi: 10.5493/wjem.v7.i3.84.
10
Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.血清白细胞介素-35 水平升高与系统性硬化症患者肺纤维化的严重程度和 Th2 反应相关。
Rheumatol Int. 2018 Aug;38(8):1511-1519. doi: 10.1007/s00296-018-4071-8. Epub 2018 May 30.

引用本文的文献

1
Immunomodulatory effects of novel nano micelle based curcumin in rheumatoid arthritis patients: A double blind randomized clinical trial.新型纳米胶束姜黄素对类风湿性关节炎患者的免疫调节作用:一项双盲随机临床试验。
Rheumatol Immunol Res. 2025 Jan 9;5(4):227-234. doi: 10.1515/rir-2024-0031. eCollection 2024 Dec.
2
Serum soluble interleukin-2 receptor alpha may predict tubulointerstitial inflammatory cell infiltration and short-term disease progression in immunoglobin A nephropathy.血清可溶性白细胞介素-2受体α可能预测免疫球蛋白A肾病的肾小管间质炎性细胞浸润及短期疾病进展。
Immunol Res. 2024 Dec;72(6):1350-1364. doi: 10.1007/s12026-024-09533-1. Epub 2024 Sep 14.
3

本文引用的文献

1
Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential.系统性硬化症中表观遗传学的进展:分子机制和治疗潜力。
Nat Rev Rheumatol. 2021 Oct;17(10):596-607. doi: 10.1038/s41584-021-00683-2. Epub 2021 Sep 3.
2
T Cells in Fibrosis and Fibrotic Diseases.T 细胞与纤维化及纤维性疾病
Front Immunol. 2020 Jun 26;11:1142. doi: 10.3389/fimmu.2020.01142. eCollection 2020.
3
Musculoskeletal hand involvement in systemic sclerosis.系统性硬化症的肌肉骨骼手部受累。
Associations of the circulating levels of cytokines with risk of systemic sclerosis: a bidirectional Mendelian randomized study.
细胞因子的循环水平与系统性硬化症风险的关联:一项双向孟德尔随机研究。
Front Immunol. 2024 Feb 28;15:1330560. doi: 10.3389/fimmu.2024.1330560. eCollection 2024.
4
A therapy that modulates T lymphocyte subsets in patients infected with Epstein-Barr virus: Ganciclovir combined with interferon atomization inhalation.一种调节感染 Epstein-Barr 病毒患者 T 淋巴细胞亚群的治疗方法:更昔洛韦联合干扰素雾化吸入。
Medicine (Baltimore). 2023 Aug 25;102(34):e34946. doi: 10.1097/MD.0000000000034946.
5
Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis.系统性硬化症治疗中的新型治疗策略
Pharmaceuticals (Basel). 2023 Jul 27;16(8):1066. doi: 10.3390/ph16081066.
Semin Arthritis Rheum. 2020 Apr;50(2):329-334. doi: 10.1016/j.semarthrit.2019.11.003. Epub 2019 Nov 9.
4
Pathophysiology of systemic sclerosis: current understanding and new insights.系统性硬化症的病理生理学:当前认识和新见解。
Expert Rev Clin Immunol. 2019 Jul;15(7):753-764. doi: 10.1080/1744666X.2019.1614915. Epub 2019 May 13.
5
Targeting Interleukin-6 Signaling in Clinic.靶向白细胞介素-6 信号通路的治疗策略。
Immunity. 2019 Apr 16;50(4):1007-1023. doi: 10.1016/j.immuni.2019.03.026.
6
Antinuclear Antibodies in Systemic Sclerosis: an Update.抗核抗体在系统性硬化症中的研究进展。
Clin Rev Allergy Immunol. 2020 Feb;58(1):40-51. doi: 10.1007/s12016-018-8718-8.
7
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).早期弥漫性皮肤系统性硬化症的治疗结果:欧洲硬皮病观察研究(ESOS)
Ann Rheum Dis. 2017 Jul;76(7):1207-1218. doi: 10.1136/annrheumdis-2016-210503. Epub 2017 Feb 10.
8
Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.系统性硬化症患者血清白细胞介素-6及其与疾病参数和心肺受累情况的相关性
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Dec 23;33(4):321-330.
9
Current perspectives on the immunopathogenesis of systemic sclerosis.系统性硬化症免疫发病机制的当前观点
Immunotargets Ther. 2016 Apr 11;5:21-35. doi: 10.2147/ITT.S82037. eCollection 2016.
10
Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review.系统性硬化症中的调节性 T 细胞:全面综述。
Clin Rev Allergy Immunol. 2017 Apr;52(2):194-201. doi: 10.1007/s12016-016-8563-6.